Michael Peyton

Weatherford College — United States

Medicine · Health Sciences

52h-index13.8kcitations324works4.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(134), Cancer Genomics and Diagnostics(34), Lung Cancer Research Studies(33), DNA Repair Mechanisms(32), RNA modifications and cancer(31)

Publications321 total

RIPK1 regulates β-cell fate via actions on gene expression and kinase signaling in a mouse model of β-cell self-reactivity
2025Open Access
Editor’s Note: <i>PTEN</i> Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR
Cancer Research·2025Open Access
Dietary Niche Variation in an Invasive Omnivore: The Effects of Habitat on Feral Pig Resource Use in Hawai‘i
Ecology and Evolution·2024· 2 citedOpen Access
Jumonji histone demethylases are therapeutic targets in small cell lung cancer
Oncogene·2024· 5 citedOpen Access
Dietary niche variation in an invasive omnivore: the effects of habitat and anthropogenic inputs on feral pig (Sus scrofa) resource use
2024
Improper data practices erode the quality of global ecological databases and impede the progress of ecological research
Global Change Biology·2024· 21 citedOpen Access
Feral pig (<i>Sus scrofa</i>) disturbance facilitates establishment of resource‐acquisitive species in Hawaiian forest understories
Functional Ecology·2023· 5 citedOpen Access
ASCL1-ERK1/2 Axis: ASCL1 restrains ERK1/2 via the dual specificity phosphatase DUSP6 to promote survival of a subset of neuroendocrine lung cancers
2023· 3 citedOpen Access
Abstract 2690: <i>In vivo</i> CRISPR screen identifies SOAT1 as a chemotherapy chemosensitizing target for non-small cell lung cancer (NSCLC)
Cancer Research·2023· 1 cited
Supplementary Figure Legends 1-4 from Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
2023Open Access
Supplementary Table 1 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1
2023Open Access
Supplementary Figure 1 from Stromal Platelet-Derived Growth Factor Receptor α (PDGFRα) Provides a Therapeutic Target Independent of Tumor Cell PDGFRα Expression in Lung Cancer Xenografts
2023Open Access
Supplementary Figures 1-4 from Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
2023Open Access
Supplementary Figure Legend from Stromal Platelet-Derived Growth Factor Receptor α (PDGFRα) Provides a Therapeutic Target Independent of Tumor Cell PDGFRα Expression in Lung Cancer Xenografts
2023Open Access
Supplementary Figures S1 - S11 from Co-occurring Genomic Alterations Define Major Subsets of &lt;i&gt;KRAS&lt;/i&gt;-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities
2023Open Access
Supplementary Methods, Table S2 from Co-occurring Genomic Alterations Define Major Subsets of &lt;i&gt;KRAS&lt;/i&gt;-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities
2023Open Access
Supplementary Tables 1-2 from Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
2023Open Access
Supplementary Methods and Figure Legend from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1
2023Open Access
Supplementary Tables 1-2 from Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
2023Open Access
Supplementary Table 3 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1
2023Open Access
page 1 of 17Next →

Frequent Co-authors

John D. Minna(41), Luc Girard(26), Adi F. Gazdar(18), Ignacio I. Wistuba(10), John V. Heymach(8), Yang Xie(8), Jerry W. Shay(6), Lauren A. Byers(5), Roy S. Herbst(5), Lutz Birnbaumer(5), Mitsuo Sato(5), Rolf A. Brekken(5), Lixia Diao(4), Gordon B. Mills(4), Kevin R. Coombes(4), Carmen Behrens(4), Meisheng Jiang(4), Michael G. Roth(4), Michael A. White(4), David S. Shames(4)